TEVA PHARMACEUTICAL INDUSTRIES LIMITED Impairment of Long-Lived Assets to be Disposed of
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Impairment of Long-Lived Assets to be Disposed of of $247.00 million for the 3-month period ending 2021-03-31, per its 10-K filed 2022-02-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2022-02-09
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of long-lived assets to be disposed of for the quarter ending 2021-03-31 was $247.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of long-lived assets to be disposed of for the quarter ending 2020-06-30 was $247.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of long-lived assets to be disposed of for fiscal 2020 was $247.00M.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 3 month as first filed | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|---|---|
| 2021-03-31 | $247.00M 10-K · filed 2022-02-09 | |||
| 2020-12-31 | $247.00M 10-K · filed 2022-02-09 | |||
| 2020-06-30 | $247.00M 10-K · filed 2021-02-10 | $261.00M 10-Q · filed 2020-11-05 | $261.00M 10-Q · filed 2020-08-05 |